US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 0.8364
- -0.0429-4.88%
Close May 7 16:00 ET
- 0.8500
- +0.0136+1.63%
Post 19:38 ET
3.84MMarket Cap-160P/E (TTM)
0.9200High0.8111Low179.30KVolume0.8998Open0.8793Pre Close155.59KTurnover3.93%Turnover RatioLossP/E (Static)4.59MShares6.850052wk High0.50P/B3.81MFloat Cap0.500052wk Low--Dividend TTM4.56MShs Float346.4999Historical High--Div YieldTTM12.39%Amplitude0.5000Historical Low0.8670Avg Price1Lot Size
About Phio Pharmaceuticals Company
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
Company Profile
SymbolPHIO
Company NamePhio Pharmaceuticals
Listing DateFeb 11, 2014
Founded2011
CEOMr. Robert J. Bitterman
MarketNASDAQ
Employees9
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11 Apex Drive,Suite 300A PMB 2006
CityMarlborough
ProvinceMassachusetts
CountryUnited States of America
Zip Code01752
Phone1-508-767-3861
Websitehttp://www.phiopharma.com
Company Executives
- Name
- Position
- Salary
- Robert J. Bitterman
- Principal Financial Officer, Chairman of the Board, Chief Executive Officer and President
- 109.38K
- Caitlin Kontulis
- Principal Accounting Officer, Vice President, Finance and Administration and Secretary
- --
- Dr. Geert Cauwenbergh, B.Med.Sc.
- Director
- 77.36K
- Dr. Jonathan E. Freeman, PhD
- Independent Director
- 39.86K
- Patricia A. Bradford
- Independent Director
- 42.29K
- Dr. Curtis A. Lockshin, PhD
- Independent Director
- 47.36K
- Robert L. Ferrara
- Lead Independent Director
- 57.99K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg